LAMP2 and prostate cancer: It was discovered that SFN therapy boosted the levels of the crucial autophagy regulators HSP90AA1 and UVRAG as well as the lysosome-associated membrane protein 2 (LAMP2) mRNA and protein in human prostate cancer cells (Hahm et al. 2020).